Oncology Practice Loan Requirements: What Lenders Look For
Understanding oncology practice loan requirements before you apply can make the financing process smoother and help you present your practice in the strongest possible light. Whether you are buying a practice, adding an infusion suite, refinancing debt or purchasing equipment, lenders look at a familiar set of factors, but oncology adds a few of its own.
Large drug purchases, heavy Medicare exposure and expensive equipment mean lenders often look more closely at cash flow timing and reimbursement risk than they might for other specialties. This article explains what lenders typically review. Requirements vary by lender and program, every loan is subject to approval, and nothing here is legal, tax, billing or compliance advice.
Cash Flow and Debt Service Coverage
The central question for most lenders is whether the practice generates enough cash to pay its existing obligations, compensate its physicians reasonably and cover the new loan payment with room to spare.
Lenders generally review several years of tax returns and financial statements, along with year-to-date results. For oncology practices, they may also ask how drug costs and drug revenue are recorded, because pass-through drug revenue can make collections look larger than the earnings the practice actually keeps.
Drug Margin and Inventory
Buy-and-bill purchasing is one of the features that sets oncology apart. The practice purchases drugs, administers them and is reimbursed later. Lenders may want to understand:
- How drug revenue and drug costs trend over time
- Typical inventory levels and purchasing terms
- How quickly drug claims are paid by major payers
- Whether the practice relies on a working capital line to bridge purchases
A clear explanation of drug economics can help a lender see the practice’s true earning power.
Payer Mix and Reimbursement Exposure
Many oncology practices depend heavily on Medicare for both professional services and Part B drugs. Lenders understand this, but they may weigh how sensitive the practice is to reimbursement changes and whether any single commercial payer represents an outsized share of revenue.
Our article on oncology practice payer mix explains how lenders think about Medicare concentration and what owners can document to address it.
Oncology Practice Loan Requirements for Borrowers
Lenders look at the people as well as the practice. Typical oncology practice loan requirements on the borrower side include:
- Clinical credentials: board certification, licensure and hospital privileges
- Management experience: prior ownership, partnership or leadership roles
- Personal credit history: payment history and existing obligations
- Personal financial statement: assets, liabilities and contingent obligations
- Liquidity: cash and investments available after closing
For acquisitions and start-ups, lenders often want to see that the borrower has both the clinical and business experience to run the practice.
Equity Injection and Down Payment
Many acquisition and real estate loans require the borrower to contribute equity. The amount depends on the program, the lender, the borrower’s profile and the risk of the deal. Our guide to the oncology practice down payment explains how lenders think about equity and what sources may be acceptable.
Use of Proceeds and Deal Structure
Lenders want a clear explanation of how loan funds will be used. A typical request may combine several uses:
- Purchase price for a practice or partner interest
- Drug inventory and working capital
- Equipment such as infusion chairs, imaging or radiation systems
- Leasehold improvements or real estate
- Refinancing of existing debt
The structure should match the asset being financed. Real estate and long-lived equipment may support longer terms, while working capital needs are often handled through a separate line.
Documents to Prepare
Gathering documents in advance can help keep the process moving. Lenders commonly request:
- Business and personal tax returns for several years
- Year-to-date profit and loss statement and balance sheet
- Accounts receivable aging and payer reports
- Debt schedule, including equipment leases and loans
- Practice lease or real estate documents
- Purchase agreement, letter of intent or project budget
- Resumes, licenses and certifications for key physicians
Matching Requirements to Loan Type
Different programs apply different standards. SBA 7(a) loans may be used for acquisitions, partner buyouts, working capital and real estate, with eligibility and terms depending on the business, the buyer, use of proceeds, program rules and lender review. Our article on the SBA loan for an oncology practice covers how program limits interact with larger oncology deals.
Conventional practice loans follow each lender’s own underwriting and may suit established practices or larger transactions. You can model potential payments with our conventional loan calculator; estimates are for planning only and do not represent an offer or approval.
Gaps That Can Slow a Decision
Applications tend to stall when financial statements do not separate drug costs clearly, when add-backs are undocumented or when the borrower has not planned for working capital after closing. Addressing these items early may help a lender reach a decision with fewer follow-up requests.
Other gaps include unexplained swings in drug purchases from one year to the next, missing details on equipment leases and unclear plans for physician coverage if a key oncologist reduces hours. A short written summary of the practice, its physicians, its service lines and the purpose of the loan can answer many of these questions before they are asked.
Final Thoughts
Oncology practice loan requirements center on cash flow, drug economics, payer exposure, borrower experience and a clear plan for the funds. Owners who understand how lenders read an oncology income statement, and who prepare documentation in advance, are better positioned to find financing that fits the practice.
US Medical Funding helps oncologists prepare for and secure practice financing. Learn more about our full range of oncology practice financing options.
